Microbiomes in pancreatic cancer can be an accomplice or a weapon
- 8 January 2024
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 194, 104262
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82373109)
This publication has 114 references indexed in Scilit:
- GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microgliaJournal of Neuroinflammation, 2012
- An NF-κB pathway–mediated positive feedback loop amplifies Ras activity to pathological levels in miceJournal of Clinical Investigation, 2012
- Microbiome and MalignancyCell Host & Microbe, 2011
- Pancreatitis-Induced Inflammation Contributes to Pancreatic Cancer by Inhibiting Oncogene-Induced SenescenceCancer Cell, 2011
- Effects of a histone deacetylase inhibitor, sodium butyrate, on 53-kDa protein expression and sensitivity to anticancer drugs of pancreatic cancer cellsCurrent Therapeutic Research, 2010
- Pancreatic cancer in chronic hepatitis BLiver International, 2010
- A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancerBMC Cancer, 2008
- Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cellsBMC Microbiology, 2008
- Bile acids induce energy expenditure by promoting intracellular thyroid hormone activationNature, 2006
- Sodium butyrate sensitises human pancreatic cancer cells to both the intrinsic and the extrinsic apoptotic pathwaysBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2005